FUM Relative Valuation - Futura Medical PLC - Alpha Spread

Futura Medical PLC
LSE:FUM

Watchlist Manager
Futura Medical PLC Logo
Futura Medical PLC
LSE:FUM
Watchlist
Price: 32.55 GBX -3.56% Market Closed
Market Cap: 98.3m GBX
Have any thoughts about
Futura Medical PLC?
Write Note

Relative Value

The Relative Value of one FUM stock under the Base Case scenario is 21.03 GBX. Compared to the current market price of 32.55 GBX, Futura Medical PLC is Overvalued by 35%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

FUM Relative Value
Base Case
21.03 GBX
Overvaluation 35%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
42
vs Industry
7
Median 3Y
0
Median 5Y
0
Industry
2.6
Forward
7
vs History
vs Industry
Median 3Y
-21.2
Median 5Y
-18.2
Industry
22.9
Forward
-34.5
vs History
vs Industry
2
Median 3Y
-25.4
Median 5Y
-21.8
Industry
17.6
vs History
vs Industry
Median 3Y
-24.1
Median 5Y
-21.4
Industry
25.2
vs History
65
vs Industry
5
Median 3Y
12.7
Median 5Y
15.7
Industry
2.2
vs History
42
vs Industry
7
Median 3Y
0
Median 5Y
0
Industry
2.7
Forward
6.4
vs History
23
vs Industry
4
Median 3Y
0
Median 5Y
0
Industry
5.4
vs History
vs Industry
9
Median 3Y
-17.3
Median 5Y
-14.7
Industry
13.9
Forward
73.9
vs History
vs Industry
10
Median 3Y
-17.3
Median 5Y
-14.6
Industry
17.3
Forward
-27.8
vs History
vs Industry
2
Median 3Y
-24
Median 5Y
-19.6
Industry
16.1
vs History
vs Industry
12
Median 3Y
-22.9
Median 5Y
-19.2
Industry
18.8
vs History
68
vs Industry
2
Median 3Y
67.1
Median 5Y
68.6
Industry
2

Multiples Across Competitors

FUM Competitors Multiples
Futura Medical PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Futura Medical PLC
LSE:FUM
97.3m GBP 11.6 -25.9 -22 -21.4
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
843.2B USD 21.7 114.8 57.4 64.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.4T DKK 13.3 38.2 25.5 29.2
US
Johnson & Johnson
NYSE:JNJ
385.8B USD 4.5 10.1 12.4 16.1
US
Merck & Co Inc
NYSE:MRK
278.3B USD 4.5 20.3 13.7 16.8
CH
Roche Holding AG
SIX:ROG
206.1B CHF 3.5 17.9 10.1 12
UK
AstraZeneca PLC
NASDAQ:AZN
240.2B USD 4.9 37.3 17.1 25.6
CH
Novartis AG
SIX:NOVN
191.2B CHF 4.6 13.8 10.9 16.1
US
Pfizer Inc
NYSE:PFE
162B USD 2.9 -62.4 12.6 20.4
P/E Multiple
Earnings Growth
UK
Futura Medical PLC
LSE:FUM
Average P/E: 36.1
Negative Multiple: -25.9
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
114.8
425%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
38.2
90%
US
Johnson & Johnson
NYSE:JNJ
10.1
-22%
US
Merck & Co Inc
NYSE:MRK
20.3
7 419%
CH
Roche Holding AG
SIX:ROG
17.9
30%
UK
A
AstraZeneca PLC
NASDAQ:AZN
37.3
175%
CH
Novartis AG
SIX:NOVN
13.8
19%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -62.4
712%
EV/EBITDA Multiple
EBITDA Growth
UK
Futura Medical PLC
LSE:FUM
Average EV/EBITDA: 445.1
Negative Multiple: -22
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 459 134.4 N/A
US
Eli Lilly and Co
NYSE:LLY
57.4
191%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
151%
DK
Novo Nordisk A/S
CSE:NOVO B
25.5
86%
US
Johnson & Johnson
NYSE:JNJ
12.4
12%
US
Merck & Co Inc
NYSE:MRK
13.7
342%
CH
Roche Holding AG
SIX:ROG
10.1
21%
UK
A
AstraZeneca PLC
NASDAQ:AZN
17.1
60%
CH
Novartis AG
SIX:NOVN
10.9
9%
US
Pfizer Inc
NYSE:PFE
12.6
30%
EV/EBIT Multiple
EBIT Growth
UK
Futura Medical PLC
LSE:FUM
Average EV/EBIT: 1 989.2
Negative Multiple: -21.4
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A
US
Eli Lilly and Co
NYSE:LLY
64.3
162%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
675%
DK
Novo Nordisk A/S
CSE:NOVO B
29.2
89%
US
Johnson & Johnson
NYSE:JNJ
16.1
29%
US
Merck & Co Inc
NYSE:MRK
16.8
717%
CH
Roche Holding AG
SIX:ROG
12
25%
UK
A
AstraZeneca PLC
NASDAQ:AZN
25.6
131%
CH
Novartis AG
SIX:NOVN
16.1
54%
US
Pfizer Inc
NYSE:PFE
20.4
60%

See Also

Discover More
Back to Top